TABLE 4.
All T3‐T4 GSSC patients (N = 394) | |||
---|---|---|---|
Low risk (total point ≤150) | High risk (total point >150) | P‐value | |
(N = 172, %) | (N = 222, %) | ||
Negative LNM | 164 (95.3) | 166 (74.8) | .000 |
Positive LNM | 8 (4.7) | 56 (25.2) |
All T3‐T4 GSSC patients (N = 394) | |||
---|---|---|---|
Low risk (total point ≤150) | High risk (total point >150) | P‐value | |
(N = 172, %) | (N = 222, %) | ||
Negative LNM | 164 (95.3) | 166 (74.8) | .000 |
Positive LNM | 8 (4.7) | 56 (25.2) |